Td Asset Management Inc Bio N Tech Se Put Options Transaction History
Td Asset Management Inc
- $102 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|---|---|---|---|---|
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
Others Institutions Holding BNTX
# of Institutions
351Shares Held
39.6MCall Options Held
2.39MPut Options Held
1.7M-
Baillie Gifford & CO8.16MShares$794 Million0.67% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.26MShares$414 Million1.71% of portfolio
-
Primecap Management CO Pasadena, CA4.05MShares$394 Million0.31% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$184 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$176 Million1.03% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $23.6B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...